L
Lucence is a precision oncology company committed to bringing clarity to cancer care. Lucence makes ultrasensitive non-invasive liquid biopsy tests to provide doctors and their patients life-changing information to enable earlier detection and effective treatment. Headquartered in Palo Alto and Singapore, Lucence supplies personalized cancer care services through twin CLIA-licensed laboratories in the United States and Singapore. For more information, visit www.lucence.com.
Investor insights
Funding rounds participated in
$20M sweet spot round size
Investor type
Privately Held
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Date founded
2016
Funding rounds raised
Total raised
$20M
from 2 investors over 1 rounds
L
Lucence raised $20M on December 20, 2019
Investors: IHH Healthcare Berhad and + 3 Other investors